| Authors: |
Landré B; Inserm U1153, Epidemiology of Ageing and Neurodegenerative Diseases, CRESS, Université Paris Cité, 10 Avenue de Verdun, Paris, 75010, France. benjamin.landre@u-paris.fr., Fayosse A; Inserm U1153, Epidemiology of Ageing and Neurodegenerative Diseases, CRESS, Université Paris Cité, 10 Avenue de Verdun, Paris, 75010, France., Jacob L; Inserm U1153, Epidemiology of Ageing and Neurodegenerative Diseases, CRESS, Université Paris Cité, 10 Avenue de Verdun, Paris, 75010, France.; Department of Physical Medicine and Rehabilitation, Lariboisière-Fernand Widal Hospital, AP-HP, Université Paris Cité, Paris, France.; Research and Development Unit, Parc Sanitari Sant Joan de Déu, CIBERSAM, ISCIII, Dr. Antoni Pujadas, 42, Sant Boi de Llobregat, Barcelona, Spain., Bloomberg M; Department of Behavioural Science and Health, University College London, London, UK., Danilevicz I; Inserm U1153, Epidemiology of Ageing and Neurodegenerative Diseases, CRESS, Université Paris Cité, 10 Avenue de Verdun, Paris, 75010, France., van der Heide F; Inserm U1153, Epidemiology of Ageing and Neurodegenerative Diseases, CRESS, Université Paris Cité, 10 Avenue de Verdun, Paris, 75010, France., Sabia S; Inserm U1153, Epidemiology of Ageing and Neurodegenerative Diseases, CRESS, Université Paris Cité, 10 Avenue de Verdun, Paris, 75010, France.; UCL Brain Sciences, University College London, London, UK., Singh-Manoux A; Inserm U1153, Epidemiology of Ageing and Neurodegenerative Diseases, CRESS, Université Paris Cité, 10 Avenue de Verdun, Paris, 75010, France.; UCL Brain Sciences, University College London, London, UK. |
